Background: Detection of Plasmodium antigens provides evidence of malaria infection status and is the basis for most malaria diagnosis. Methods: We developed a sensitive bead-based multiplex assay for laboratory use, which simultaneously detects pan-Plasmodium aldolase (pAldo), pan-Plasmodium lactate dehydrogenase (pLDH), and P. falciparum histidine-rich protein 2 (PfHRP2) antigens. The assay was validated against purified recombinant antigens, monospecies malaria infections, and noninfected blood samples. To test against samples collected in an endemic setting, Angolan outpatient samples (n = 1267) were assayed. Results: Of 466 Angolan samples positive for at least 1 antigen, the most common antigen profiles were PfHRP2+/pAldo+/pLDH+ (167, 36%), PfHRP2+/pAldo-/pLDH- (163, 35%), and PfHRP2+/pAldo+/pLDH- (129, 28%). Antigen profile was predictive of polymerase chain reaction (PCR) positivity and parasite density. Eight Angolan samples (1.7%) had no or very low PfHRP2 but were positive for 1 or both of the other antigens. PCR analysis confirmed 3 (0.6%) were P. ovale infections and 2 (0.4%) represented P. falciparum parasites lacking Pfhrp2 and/or Pfhrp3. Conclusions: These are the first reports of Pfhrp2/3 deletion mutants in Angola. High-throughput multiplex antigen detection can inexpensively screen for low-density P. falciparum, non-falciparum, and Pfhrp2/3-deleted parasites to provide population-level antigen estimates and identify specimens requiring further molecular characterization.
Background: Detection of Plasmodium antigens provides evidence of malaria infection status and is the basis for most malaria diagnosis. Methods: We developed a sensitive bead-based multiplex assay for laboratory use, which simultaneously detects pan-Plasmodium aldolase (pAldo), pan-Plasmodium lactate dehydrogenase (pLDH), and P. falciparumhistidine-rich protein 2 (PfHRP2) antigens. The assay was validated against purified recombinant antigens, monospecies malaria infections, and noninfected blood samples. To test against samples collected in an endemic setting, Angolan outpatient samples (n = 1267) were assayed. Results: Of 466 Angolan samples positive for at least 1 antigen, the most common antigen profiles were PfHRP2+/pAldo+/pLDH+ (167, 36%), PfHRP2+/pAldo-/pLDH- (163, 35%), and PfHRP2+/pAldo+/pLDH- (129, 28%). Antigen profile was predictive of polymerase chain reaction (PCR) positivity and parasite density. Eight Angolan samples (1.7%) had no or very low PfHRP2 but were positive for 1 or both of the other antigens. PCR analysis confirmed 3 (0.6%) were P. ovale infections and 2 (0.4%) represented P. falciparum parasites lacking Pfhrp2 and/or Pfhrp3. Conclusions: These are the first reports of Pfhrp2/3 deletion mutants in Angola. High-throughput multiplex antigen detection can inexpensively screen for low-density P. falciparum, non-falciparum, and Pfhrp2/3-deleted parasites to provide population-level antigen estimates and identify specimens requiring further molecular characterization.
Authors: Jonathan B Parr; Robert Verity; Stephanie M Doctor; Mark Janko; Kelly Carey-Ewend; Breanna J Turman; Corinna Keeler; Hannah C Slater; Amy N Whitesell; Kashamuka Mwandagalirwa; Azra C Ghani; Joris L Likwela; Antoinette K Tshefu; Michael Emch; Jonathan J Juliano; Steven R Meshnick Journal: J Infect Dis Date: 2017-07-01 Impact factor: 5.226
Authors: Mateusz M Plucinski; Eric Rogier; Pedro Rafael Dimbu; Filomeno Fortes; Eric S Halsey; Michael Aidoo Journal: Am J Trop Med Hyg Date: 2017-07-19 Impact factor: 2.345
Authors: Dionicia Gamboa; Mei-Fong Ho; Jorge Bendezu; Katherine Torres; Peter L Chiodini; John W Barnwell; Sandra Incardona; Mark Perkins; David Bell; James McCarthy; Qin Cheng Journal: PLoS One Date: 2010-01-25 Impact factor: 3.240
Authors: Otília Lupi; Felipe Ridolfi; Sidnei da Silva; Graziela Maria Zanini; Aline Lavigne; Rita Maria Ribeiro Nogueira; Maria de Fátima Ferreira da Cruz; Cláudio Tadeu Daniel-Ribeiro; Patrícia Brasil Journal: Int J Infect Dis Date: 2016-01-22 Impact factor: 3.623
Authors: Qin Cheng; Michelle L Gatton; John Barnwell; Peter Chiodini; James McCarthy; David Bell; Jane Cunningham Journal: Malar J Date: 2014-07-22 Impact factor: 2.979
Authors: Mateusz M Plucinski; Eric Rogier; Pedro Rafael Dimbu; Filomeno Fortes; Eric S Halsey; Michael Aidoo; Tom Smith Journal: J Clin Microbiol Date: 2019-02-27 Impact factor: 5.948
Authors: Mateusz M Plucinski; Baltazar Candrinho; Mercia Dimene; Tom Smith; Julie Thwing; James Colborn; Eric Rogier; Rose Zulliger Journal: Am J Trop Med Hyg Date: 2020-01 Impact factor: 2.345
Authors: Eric Rogier; Karen E S Hamre; Vena Joseph; Mateusz M Plucinski; Jacquelin Presume; Ithamare Romilus; Gina Mondelus; Tamara Elisme; Lotus van den Hoogen; Jean Frantz Lemoine; Chris Drakeley; Ruth A Ashton; Michelle A Chang; Alexandre Existe; Jacques Boncy; Gillian Stresman; Thomas Druetz; Thomas P Eisele Journal: J Infect Dis Date: 2020-02-18 Impact factor: 5.226
Authors: Eric Rogier; Doug Nace; Dragan Ljolje; Naomi W Lucchi; Venkatachalam Udhayakumar; Michael Aidoo Journal: Am J Trop Med Hyg Date: 2020-05 Impact factor: 2.345
Authors: José Franco Martins; Cátia Marques; Benjamin Nieto-Andrade; Julia Kelley; Dhruviben Patel; Doug Nace; Camelia Herman; Joel Barratt; Gabriel Ponce de León; Eldin Talundzic; Eric Rogier; Eric S Halsey; Mateusz M Plucinski Journal: Am J Trop Med Hyg Date: 2020-11 Impact factor: 2.345